CURRENT STATUS
MAY, RECRUITMENT
The study was initially planned to randomize approximately 200 patients. The first patient entered the study in May 2019. The recruitment was estimated to be completed in June 2020 but was prolonged several times and finally stopped after 30 months, at which point 129 patients had been screened and 125 randomized.